These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3543937)

  • 1. Immortality of cell cultures derived from brains of mice and hamsters infected with Creutzfeldt-Jakob disease agent.
    Manuelidis EE; Fritch WW; Kim JH; Manuelidis L
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):871-5. PubMed ID: 3543937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro transformation elicited by Creutzfeldt-Jakob-infected brain material.
    Oleszak EL; Manuelidis L; Manuelidis EE
    J Neuropathol Exp Neurol; 1986 Sep; 45(5):489-502. PubMed ID: 3528396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.
    Bockman JM; Kingsbury DT
    J Virol; 1988 Sep; 62(9):3120-7. PubMed ID: 2900341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease.
    Manuelidis EE
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):1-17. PubMed ID: 3880808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain.
    Tamai Y; Kojima H; Ohtani Y; Uchida K; Taguchi F; Kawaguchi T; Miura S; Tateishi J
    Microbiol Immunol; 1989; 33(1):35-42. PubMed ID: 2659945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor production by Creutzfeldt-Jakob disease cell lines.
    Oleszak EL; Murdoch G; Manuelidis L; Manuelidis EE
    J Virol; 1988 Sep; 62(9):3103-8. PubMed ID: 3043023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ultrastructural diversity of scrapie-associated fibrils isolated from experimental scrapie and Creutzfeldt-Jakob disease.
    Liberski PP; Brown P; Xiao SY; Gajdusek DC
    J Comp Pathol; 1991 Nov; 105(4):377-86. PubMed ID: 1770176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.
    Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1993; 130(3-4):301-16. PubMed ID: 8517790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between astrocytes and oligodendroglia in human and experimental Creutzfeldt-Jakob disease and scrapie.
    Liberski PP; Brown P; Cervenakova L; Gajdusek DC
    Exp Neurol; 1997 Mar; 144(1):227-34. PubMed ID: 9126175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and spread of causative agent of Creutzfeldt-Jakob disease in intraperitoneally infected mice.
    Chino F; Ohkawa T
    Jpn J Med Sci Biol; 1990 Dec; 43(6):197-208. PubMed ID: 2101136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population.
    Manuelidis EE; Manuelidis L
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7724-8. PubMed ID: 8356076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.
    Bockman JM; Prusiner SB; Tateishi J; Kingsbury DT
    Ann Neurol; 1987 Jun; 21(6):589-95. PubMed ID: 3300520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential retroviral RNAs in Creutzfeldt-Jakob disease.
    Murdoch GH; Sklaviadis T; Manuelidis EE; Manuelidis L
    J Virol; 1990 Apr; 64(4):1477-86. PubMed ID: 2108258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation.
    Sklaviadis T; Dreyer R; Manuelidis L
    Virus Res; 1992 Dec; 26(3):241-54. PubMed ID: 1492497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease.
    Mori S; Hamada C; Kumanishi T; Fukuhara N; Ichihashi Y; Ikuta F; Miyatake T; Tsubaki T
    Neurology; 1989 Oct; 39(10):1337-42. PubMed ID: 2677833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.
    Brown P; Wolff A; Gajdusek DC
    Neurology; 1990 Jun; 40(6):887-90. PubMed ID: 1693181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial activation varies in different models of Creutzfeldt-Jakob disease.
    Baker CA; Lu ZY; Zaitsev I; Manuelidis L
    J Virol; 1999 Jun; 73(6):5089-97. PubMed ID: 10233972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease with demonstration of virus-like particles.
    Shibayama Y; Sakaguchi Y; Nakata K; Goto T; Nakai M; Takai T; Shirakata S
    Acta Pathol Jpn; 1982 Jul; 32(4):695-702. PubMed ID: 7051752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.
    Akowitz A; Sklaviadis T; Manuelidis L
    Nucleic Acids Res; 1994 Mar; 22(6):1101-7. PubMed ID: 8152913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.